| The thioredoxin system and cancer therapy: a review F Mohammadi, A Soltani, A Ghahremanloo, H Javid, SI Hashemy Cancer Chemotherapy and Pharmacology 84, 925-935, 2019 | 116 | 2019 |
| Quercetin: a promising phytochemical for the treatment of glioblastoma multiforme E Tavana, H Mollazadeh, E Mohtashami, SMS Modaresi, A Hosseini, ... BioFactors 46 (3), 356-366, 2020 | 99 | 2020 |
| The emerging role of substance P/neurokinin-1 receptor signaling pathways in growth and development of tumor cells H Javid, F Mohammadi, E Zahiri, SI Hashemy Journal of physiology and biochemistry 75, 415-421, 2019 | 65 | 2019 |
| Anti-tumor effects of curcuminoids in glioblastoma multiforme: An updated literature review AR Afshari, M Jalili-Nik, F Abbasinezhad-Moud, H Javid, M Karimi, ... Current medicinal chemistry 28 (39), 8116-8138, 2021 | 64 | 2021 |
| The role of substance P/neurokinin 1 receptor in the pathogenesis of esophageal squamous cell carcinoma through constitutively active PI3K/Akt/NF-κB signal transduction pathways H Javid, J Asadi, F Zahedi Avval, AR Afshari, SI Hashemy Molecular biology reports 47, 2253-2263, 2020 | 49 | 2020 |
| Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression F Mohammadi, H Javid, AR Afshari, B Mashkani, SI Hashemy Molecular biology reports 47, 4263-4272, 2020 | 46 | 2020 |
| RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin–RGD interactions H Javid, MA Oryani, N Rezagholinejad, A Esparham, M Tajaldini, ... Cancer Medicine 13 (2), e6800, 2024 | 41 | 2024 |
| New insight into the role of substance P/neurokinin‐1 receptor system in breast cancer progression and its crosstalk with microRNAs S Ebrahimi, H Javid, A Alaei, SI Hashemy Clinical genetics 98 (4), 322-330, 2020 | 38 | 2020 |
| Investigation of the Role of Neurokinin‐1 Receptor Inhibition Using Aprepitant in the Apoptotic Cell Death through PI3K/Akt/NF‐κB Signal Transduction Pathways in … A Ghahremanloo, H Javid, AR Afshari, SI Hashemy BioMed research international 2021 (1), 1383878, 2021 | 35 | 2021 |
| Immunotherapy for colorectal cancer: rational strategies and novel therapeutic progress F Rastin, H Javid, MA Oryani, N Rezagholinejad, AR Afshari, ... International immunopharmacology 126, 111055, 2024 | 34 | 2024 |
| Green synthesized selenium nanoparticles for ovarian cancer cell apoptosis H Amiri, SI Hashemy, Z Sabouri, H Javid, M Darroudi Research on Chemical Intermediates 47, 2539-2556, 2021 | 33 | 2021 |
| 5′‐Adenosine monophosphate‐activated protein kinase: A potential target for disease prevention by curcumin A Soltani, A Salmaninejad, M Jalili‐Nik, A Soleimani, H Javid, ... Journal of cellular physiology 234 (3), 2241-2251, 2019 | 33 | 2019 |
| The effect of SP/NK1R on the expression and activity of catalase and superoxide dismutase in glioblastoma cancer cells F Korfi, H Javid, R Assaran Darban, SI Hashemy Biochemistry Research International 2021 (1), 6620708, 2021 | 31 | 2021 |
| Neurokinin-1 receptor (NK-1R) antagonists: potential targets in the treatment of glioblastoma multiforme AR Afshari, A Motamed-Sanaye, H Sabri, A Soltani, S Karkon-Shayan, ... Current medicinal chemistry 28 (24), 4877-4892, 2021 | 29 | 2021 |
| Recent advances in glioblastoma multiforme therapy: A focus on autophagy regulation M Sanati, MM Binabaj, SS Ahmadi, S Aminyavari, H Javid, H Mollazadeh, ... Biomedicine & Pharmacotherapy 155, 113740, 2022 | 28 | 2022 |
| The therapeutic potential of aprepitant in glioblastoma cancer cells through redox modification S Rezaei, R Assaran Darban, H Javid, SI Hashemy BioMed Research International 2022 (1), 8540403, 2022 | 26 | 2022 |
| The anti-tumoral role of Hesperidin and Aprepitant on prostate cancer cells through redox modifications S Akbari, R Assaran Darban, H Javid, A Esparham, SI Hashemy Naunyn-Schmiedeberg's Archives of Pharmacology 396 (12), 3559-3567, 2023 | 24 | 2023 |
| The SP/NK1R system promotes the proliferation of breast cancer cells through NF-κB-mediated inflammatory responses S Jafarinezhad, R Assaran Darban, H Javid, SI Hashemy Cell Biochemistry and Biophysics 81 (4), 787-794, 2023 | 22 | 2023 |
| Strategy of targeting the tumor microenvironment via inhibition of fibroblast/fibrosis remodeling new era to cancer chemo-immunotherapy resistance M Tajaldini, A Poorkhani, T Amiriani, A Amiriani, H Javid, P Aref, F Ahmadi, ... European Journal of Pharmacology 957, 175991, 2023 | 22 | 2023 |
| Aprepitant Promotes Caspase‐Dependent Apoptotic Cell Death and G2/M Arrest through PI3K/Akt/NF‐κB Axis in Cancer Stem‐Like Esophageal Squamous Cell … H Javid, AR Afshari, F Zahedi Avval, J Asadi, SI Hashemy BioMed Research International 2021 (1), 8808214, 2021 | 22 | 2021 |
Seyed Isaac HashemyMashhad University of Medical Sciencesبريد إلكتروني تم التحقق منه على mums.ac.ir
